Neuroinflammation Induces Neurodegeneration

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Neurodegenerative diseases (NDs) like Alzheimer's (AD), Parkinson's (PD), and Multiple Sclerosis (MS) involve specific neuronal loss in the central nervous system (CNS).
• Unlike other tissues, damaged CNS neurons have limited regenerative capacity.
• Neurodegeneration is exacerbated by a complex interplay of inflammatory and neurotoxic mediators released by activated glial cells, neurons, and immune cells.

Purpose of the Study:

• To review the multifaceted factors contributing to neuroinflammation-mediated neurodegeneration.
• To highlight the role of various inflammatory mediators and cellular players in the pathogenesis of NDs.
• To underscore the current challenges in treating NDs due to incomplete understanding of disease mechanisms.

Main Methods:

• Literature review of studies on neuroinflammation and neurodegeneration.
• Analysis of inflammatory mediators (e.g., cytokines, chemokines, ROS) and cellular components (e.g., microglia, astrocytes, T-cells) involved.
• Examination of the blood-brain barrier's role in neuroinflammation.

Main Results:

• Specific inflammatory mediators like IL-1β, TNF-α, CCL2, ROS, and activated immune cells contribute to neuronal damage in AD, PD, and MS.
• Activated microglia and astrocytes play a central role in propagating neuroinflammation.
• A compromised blood-brain barrier allows peripheral inflammatory factors to worsen CNS inflammation.

Conclusions:

• Neuroinflammation is a critical component in the onset and progression of neurodegenerative diseases.
• Despite the crucial role of inflammation, current anti-inflammatory therapies show limited efficacy, indicating a need for deeper mechanistic understanding.
• Further research into the specific factors driving neuroinflammation is essential for developing targeted and effective treatments for neurodegenerative conditions.